Polymorphism, Restriction Fragment Length
"Polymorphism, Restriction Fragment Length" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment.
| Descriptor ID |
D012150
|
| MeSH Number(s) |
G05.365.795.595
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Polymorphism, Restriction Fragment Length".
Below are MeSH descriptors whose meaning is more specific than "Polymorphism, Restriction Fragment Length".
This graph shows the total number of publications written about "Polymorphism, Restriction Fragment Length" by people in this website by year, and whether "Polymorphism, Restriction Fragment Length" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 3 | 4 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 2 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 3 | 4 |
| 2005 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Polymorphism, Restriction Fragment Length" by people in Profiles.
-
Zeng-Brouwers J, Beckmann J, Nastase MV, Iozzo RV, Schaefer L. De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88/TRIF pathways. Matrix Biol. 2014 Apr; 35:132-42.
-
Barnholtz-Sloan JS, Guan X, Zeigler-Johnson C, Meropol NJ, Rebbeck TR. Decision tree-based modeling of androgen pathway genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2011 Jun; 20(6):1146-55.
-
Hasan R, Jabeen K, Ali A, Rafiq Y, Laiq R, Malik B, Tanveer M, Groenheit R, Ghebremichael S, Hoffner S, Hasan Z. Extensively drug-resistant tuberculosis, Pakistan. Emerg Infect Dis. 2010 Sep; 16(9):1473-5.
-
Glas J, Beynon V, Bachstein B, Steckenbiller J, Manolis V, Euba A, M?ller-Myhsok B, Folwaczny M. Increased plasma concentration of surfactant protein D in chronic periodontitis independent of SFTPD genotype: potential role as a biomarker. Tissue Antigens. 2008 Jul; 72(1):21-8.
-
Pulido JS, McConnell JP, Lennon RJ, Bryant SC, Peterson LM, Berger PB, Somers V, Highsmith WE. Relationship between age-related macular degeneration-associated variants of complement factor H and LOC387715 with coronary artery disease. Mayo Clin Proc. 2007 Mar; 82(3):301-7.
-
Lohoff FW, Ferraro TN, Sander T, Zhao H, Dahl JP, Berrettini WH, Buono RJ. No association between common variations in the human alpha 2 subunit gene (ATP1A2) of the sodium-potassium-transporting ATPase and idiopathic generalized epilepsy. Neurosci Lett. 2005 Jul 1-8; 382(1-2):33-8.
-
Papachristou GI, Sass DA, Avula H, Lamb J, Lokshin A, Barmada MM, Slivka A, Whitcomb DC. Is the monocyte chemotactic protein-1 -2518 G allele a risk factor for severe acute pancreatitis? Clin Gastroenterol Hepatol. 2005 May; 3(5):475-81.
-
Kim SU, Lee KM, Park SK, Yoo KY, Noh DY, Choe KJ, Ahn SH, Hirvonen A, Kang D. Genetic polymorphism of glutathione S-transferase P1 and breast cancer risk. J Biochem Mol Biol. 2004 Sep 30; 37(5):582-5.
-
Lee SA, Kang D, Nishio H, Lee MJ, Kim DH, Han W, Yoo KY, Ahn SH, Choe KJ, Hirvonen A, Noh DY. Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women. Exp Mol Med. 2004 Apr 30; 36(2):116-21.
-
Zeigler-Johnson C, Panossian S, Gueye SM, Jalloh M, Ofori-Adjei D, Kanetsky PA. Population differences in the frequency of the agouti signaling protein g.8818a>G polymorphism. Pigment Cell Res. 2004 Apr; 17(2):185-7.